These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9469647)

  • 1. Preventive effects of Hange-shashin-to on irinotecan hydrochloride-caused diarrhea and its relevance to the colonic prostaglandin E2 and water absorption in the rat.
    Kase Y; Hayakawa T; Aburada M; Komatsu Y; Kamataki T
    Jpn J Pharmacol; 1997 Dec; 75(4):407-13. PubMed ID: 9469647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of irinotecan hydrochloride-induced diarrhea to the level of prostaglandin E2 and water absorption of large intestine in rats.
    Kase Y; Hayakawa T; Togashi Y; Kamataki T
    Jpn J Pharmacol; 1997 Dec; 75(4):399-405. PubMed ID: 9469646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of Hange-shashin-to on the content of prostaglandin E2 and water absorption in the large intestine of rats.
    Kase Y; Hayakawa T; Ishige A; Aburada M; Komatsu Y
    Biol Pharm Bull; 1997 Sep; 20(9):954-7. PubMed ID: 9331975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats.
    Takasuna K; Kasai Y; Kitano Y; Mori K; Kobayashi R; Hagiwara T; Kakihata K; Hirohashi M; Nomura M; Nagai E
    Jpn J Cancer Res; 1995 Oct; 86(10):978-84. PubMed ID: 7493918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive effect of TJ-14, a kampo (Chinese herb) medicine, on diarrhea induced by irinotecan hydrochloride (CPT-11)].
    Sakata Y; Suzuki H; Kamataki T
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1241-4. PubMed ID: 8031168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.
    Takasuna K; Hagiwara T; Watanabe K; Onose S; Yoshida S; Kumazawa E; Nagai E; Kamataki T
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):494-503. PubMed ID: 16437251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the mechanisms of diarrhea induced by a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats].
    Takasuna K; Kasai Y; Kitano Y; Mori K; Kakihata K; Hirohashi M; Nomura M
    Nihon Yakurigaku Zasshi; 1995 Jun; 105(6):447-60. PubMed ID: 7557733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen.
    Kurita A; Kado S; Matsumoto T; Asakawa N; Kaneda N; Kato I; Uchida K; Onoue M; Yokokura T
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):201-13. PubMed ID: 20354702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kampo medicines for the prevention of irinotecan-induced diarrhea in advanced non-small cell lung cancer].
    Mori K; Hirose T; Machida S; Tominaga K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1159-63. PubMed ID: 9679578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats.
    Kurita A; Kado S; Kaneda N; Onoue M; Hashimoto S; Yokokura T
    Cancer Chemother Pharmacol; 2000; 46(3):211-20. PubMed ID: 11021738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model.
    Cao S; Black JD; Troutt AB; Rustum YM
    Cancer Res; 1998 Aug; 58(15):3270-4. PubMed ID: 9699654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer.
    Mori K; Kondo T; Kamiyama Y; Kano Y; Tominaga K
    Cancer Chemother Pharmacol; 2003 May; 51(5):403-6. PubMed ID: 12687289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adsorption of irinotecan onto oral adsorbent AST-120 (Kremezin) for preventing delayed diarrhea.
    Hidaka M; Yamasaki K; Okumura M; Ogikubo T; Iwakiri T; Setoguchi N; Nishida K; Nagai K; Ikenoue T; Arimori K
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):321-8. PubMed ID: 16770581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms by which Hange-shashin-to reduces prostaglandin E2 levels.
    Kase Y; Saitoh K; Ishige A; Komatsu Y
    Biol Pharm Bull; 1998 Dec; 21(12):1277-81. PubMed ID: 9881638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats.
    Takasuna K; Hagiwara T; Hirohashi M; Kato M; Nomura M; Nagai E; Yokoi T; Kamataki T
    Cancer Res; 1996 Aug; 56(16):3752-7. PubMed ID: 8706020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice.
    Wu Y; Wang D; Yang X; Fu C; Zou L; Zhang J
    Biomed Pharmacother; 2019 Jan; 109():2252-2261. PubMed ID: 30551482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset diarrhea in rats.
    Onoue M; Kurita A; Kado S; Matsumoto T; Kaneda N; Uchida K; Kato I; Yokokura T
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):595-605. PubMed ID: 17549477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion.
    Kurita A; Kado S; Kaneda N; Onoue M; Hashimoto S; Yokokura T
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):349-60. PubMed ID: 12904895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Hange-shashin-to on cholera toxin-induced fluid secretion in the small intestine of rats.
    Kase Y; Saitoh K; Yuzurihara M; Ishige A; Komatsu Y
    Biol Pharm Bull; 1998 Feb; 21(2):117-20. PubMed ID: 9514604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
    Swami U; Goel S; Mani S
    Curr Drug Targets; 2013 Jun; 14(7):777-97. PubMed ID: 23597015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.